William J. Febbo - Jul 13, 2024 Form 4 Insider Report for Augmedix, Inc. (AUGX)

Role
Director
Signature
/s/ Todd Holvick, Attorney-in-Fact
Stock symbol
AUGX
Transactions as of
Jul 13, 2024
Transactions value $
$0
Form type
4
Date filed
7/15/2024, 09:58 PM
Previous filing
Jun 12, 2024
Next filing
Oct 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUGX Common Stock Options Exercise +21.6K +15.32% 163K Jul 13, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AUGX Restricted Stock Units Options Exercise $0 -21.6K -100% $0.00* 0 Jul 13, 2024 Common Stock 21.6K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
F2 On July 13, 2023 (the "Grant Date"), the reporting person was granted 21,598 RSUs which vested in full on the one-year anniversary of the Grant Date.